Piotr Grabarczyk

Dr. Piotr Grabarczyk

Department of Virology, Institute of Hematology and Transfusion Medicine, Chocimska 5 Str., 00-957 Warsaw, Poland

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2008 in Journal of Hepatology
Verified
Journal Article
Closed access
DCDaniel Candotti
Daniel Candotti
PGPiotr Grabarczyk
Piotr Grabarczyk
PGPaola Ghiazza
Paola Ghiazza
RRRoberto Roig
Roberto Roig
NCNatalia Casamitjana
Natalia Casamitjana
JAJean-Pierre Allain
Jean-Pierre Allain

1 December 2006 in Hepatology
Verified
Journal Article
Closed access
PDF file
EBEwa Brojer
Ewa Brojer
PGPiotr Grabarczyk
Piotr Grabarczyk
GLGrzegorz Liszewski
Grzegorz Liszewski
MMMaria Mikulska
Maria Mikulska
JAJean-Pierre Allain
Jean-Pierre Allain
MLMagdalena Letowska
Magdalena Letowska

1 March 2018 in Transfusion
Verified
Journal Article
Closed access
PDF file
PGPiotr Grabarczyk
Piotr Grabarczyk
ESEwa Sulkowska
Ewa Sulkowska
JGJolanta Gdowska
Jolanta Gdowska
AKAneta Kopacz
Aneta Kopacz
GLGrzegorz Liszewski
Grzegorz Liszewski
MŁMagdalena Łętowska
Magdalena Łętowska

24 May 2013 in Postępy Higieny I Medycyny Doświadczalnej
Verified
Journal Article
Open access
EGEwelina Grywalska
Ewelina Grywalska
JMJustyna Markowicz
Justyna Markowicz
PGPiotr Grabarczyk
Piotr Grabarczyk
MPMarcin Pasiarski
Marcin Pasiarski
JRJacek Roliński
Jacek Roliński
The Epstein-Barr virus (EBV) is one of the most common human viruses, infecting more than 90% of the world's adult population. In some individuals the interplay between EBV replication, latency and immune control can be disrupted and evokes prolonged proliferation of EBV-infected lymphocytes and their malignant transformation. Since its discovery as the first human tumor virus, EBV has been implicated in the development of a wide range of human cancers. The evidence for an association with EBV is the strongest for Burkitt's lymphoma, NK/T cell lymphoma, nasopharyngeal carcinoma, Hodgkin's lymphoma and for malignant lymphomas in immune incompetent patients. Additionally, certain epithelial cell tumors, such as gastric carcinoma and breast carcinoma, have been defined as EBV related. However, the virus may be encountered in other types of malignancies. The oncogenic potential of EBV is related to its ability to infect and transform B lymphocytes into continuously growing lymphoblastoid cell lines. EBV encodes a series of products mimicking several growth, transcription and anti-apoptotic factors, to usurp control of the pathways that regulate diverse homeostatic cellular functions. However, the exact mechanism by which EBV promotes oncogenesis remains unclear. The focus of this review is to summarize the current knowledge of oncogenic potential of the Epstein-Barr virus and its role in the pathogenesis of EBV-associated lymphoproliferative disorders.

24 November 2010 in Journal of Medical Virology
Verified
Journal Article
Closed access
PDF file
PGPiotr Grabarczyk
Piotr Grabarczyk
AKAleksandra Kalińska
Aleksandra Kalińska
MKMahmut Kara
Mahmut Kara
RWRenata Wieczorek
Renata Wieczorek
AEAnna Ejduk
Anna Ejduk
EBEwa Brojer
Ewa Brojer

17 October 2013 in Transfusion
Verified
Journal Article
Closed access
PDF file
PGPiotr Grabarczyk
Piotr Grabarczyk
HDHarry van Drimmelen
Harry van Drimmelen
AKAneta Kopacz
Aneta Kopacz
JGJolanta Gdowska
Jolanta Gdowska
GLGrzegorz Liszewski
Grzegorz Liszewski
EBEwa Brojer
Ewa Brojer